You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.
2026 › April › 14
Biogen
3 months ago
Biogen could see lower royalties for Ocrevus after its patent expires , but it has developed other medicines that will support its growth, per Piper Sandler.
page 1 of 1